The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites

J. E. Hyde

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Resistance to antifolate drugs such as pyrimethamine is widespread among malaria parasites of the most pathogenic species Plasmodium falciparum. These drugs inhibit the dihydrofolate reductase activity of the dihydrofolate reductase-thymidylate synthetase (DHFR-TS) bifunctional enzyme. This review examines work done to characterize the enzyme, the cloning of plasmodial DHFR-TS genes, chromosomal mapping studies of these genes by pulsed-field gel electrophoresis, and the structural insights into the mechanism of drug resistance that have been gained by comparing genes from drug-sensitive parasites with those from drug-resistant strains that have arisen in the field or after experimental induction.
    Original languageEnglish
    Pages (from-to)45-59
    Number of pages14
    JournalPharmacology and Therapeutics
    Volume48
    Issue number1
    DOIs
    Publication statusPublished - 1990

    Fingerprint

    Dive into the research topics of 'The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites'. Together they form a unique fingerprint.

    Cite this